Genomics
5th Annual DREAM Reverse Engineering Challenges
November 16 - 20, 2010 5th Annual DREAM Reverse Engineering Challenges
New York, USA Further information
Held jointly with the 6th Annual RECOMB Satellite on Systems Biology, and the 7th Annual RECOMB Satellite on Regulatory Genomics. The goal of the meeting is to bring together computational and experimental scientists in the area of regulatory genomics and systems biology, to discuss current research directions, latest findings, and establish new collaborations towards a systems-level understanding of gene regulation. The meeting consists of keynote presentations, oral presentations selected from submitted manuscripts and 1-page abstracts, and posters presentations also selected from submitted abstracts. More than 500 participants attended last year\'s meeting, the vast majority of whom attended all three meetings, and we expect a similar interest this year.
Suggested reading: Molecular Biology Books
New York, USA Further information
Held jointly with the 6th Annual RECOMB Satellite on Systems Biology, and the 7th Annual RECOMB Satellite on Regulatory Genomics. The goal of the meeting is to bring together computational and experimental scientists in the area of regulatory genomics and systems biology, to discuss current research directions, latest findings, and establish new collaborations towards a systems-level understanding of gene regulation. The meeting consists of keynote presentations, oral presentations selected from submitted manuscripts and 1-page abstracts, and posters presentations also selected from submitted abstracts. More than 500 participants attended last year\'s meeting, the vast majority of whom attended all three meetings, and we expect a similar interest this year.
Suggested reading: Molecular Biology Books
Glycoconjugate Vaccine
Glycoconjugate Vaccine
from David R. Bundle writing in Vaccine Design: Innovative Approaches and Novel Strategies
Methods for single point attachment of polysaccharides and oligosaccharides to protein carriers and T-cell peptides are important in vaccine design. Contemporary approaches involve synthetic oligosaccharides with linker or tether chemistry designed for compatibility with synthetic strategies. Current research involves the synthesis and evaluation of conjugate vaccines designed to combat infectious bacterial and fungal diseases, as well as the design and testing of therapeutic cancer vaccine. The prevailing dogma that protective B-cell epitopes should be comprised of 10-20 monosaccharides is confirmed for several experimental vaccines including those directed toward Shigell flexneri and Shigella dysenteriae. However, several small epitopes composed of 3-5 monosaccharide residues are sufficient to induce antibody against the whole organism and to confer protection.
Further reading: Vaccine Design: Innovative Approaches and Novel Strategies
from David R. Bundle writing in Vaccine Design: Innovative Approaches and Novel Strategies
Methods for single point attachment of polysaccharides and oligosaccharides to protein carriers and T-cell peptides are important in vaccine design. Contemporary approaches involve synthetic oligosaccharides with linker or tether chemistry designed for compatibility with synthetic strategies. Current research involves the synthesis and evaluation of conjugate vaccines designed to combat infectious bacterial and fungal diseases, as well as the design and testing of therapeutic cancer vaccine. The prevailing dogma that protective B-cell epitopes should be comprised of 10-20 monosaccharides is confirmed for several experimental vaccines including those directed toward Shigell flexneri and Shigella dysenteriae. However, several small epitopes composed of 3-5 monosaccharide residues are sufficient to induce antibody against the whole organism and to confer protection.
Further reading: Vaccine Design: Innovative Approaches and Novel Strategies
Genome-derived vaccine
The first genome-derived vaccine now in clinical trials
from Fabio Bagnoli, Nathalie Norais, Ilaria Ferlenghi, Maria Scarselli, Claudio Donati, Silvana Savino, Michèle A. Barocchi and Rino Rappuoli writing in Vaccine Design: Innovative Approaches and Novel Strategies
Genome sequencing has become routine, and modern vaccine design is taking advantage of the accumulating genomic information. Reverse vaccinology is built on genome-based antigen discovery and has largely replaced classical vaccinology methods based on growing and dissecting the microorganism. The main advantage of the approach is the fast prediction of vaccine candidates. Most of the antigens will be surface exposed proteins, since these antigens are most likely accessible to antibodies. This approach can be applied to non-cultivable microorganisms, something difficult or impossible to do with conventional approaches. When the first reverse vaccinology project was started, in the year 2000, antigen identification was mainly based on bioinformatic analysis of one genome. Since then, the technique has shown its full potential, with the first genome-derived vaccine now in clinical trials and several vaccines in preclinical studies. In the meantime the approach has been improved with the support of proteomics, functional genomics and comparative genomics. The complete process includes antigen prediction to high-throughput purification, screening and selection of the vaccine composition.
Further reading: Vaccine Design: Innovative Approaches and Novel Strategies
from Fabio Bagnoli, Nathalie Norais, Ilaria Ferlenghi, Maria Scarselli, Claudio Donati, Silvana Savino, Michèle A. Barocchi and Rino Rappuoli writing in Vaccine Design: Innovative Approaches and Novel Strategies
Genome sequencing has become routine, and modern vaccine design is taking advantage of the accumulating genomic information. Reverse vaccinology is built on genome-based antigen discovery and has largely replaced classical vaccinology methods based on growing and dissecting the microorganism. The main advantage of the approach is the fast prediction of vaccine candidates. Most of the antigens will be surface exposed proteins, since these antigens are most likely accessible to antibodies. This approach can be applied to non-cultivable microorganisms, something difficult or impossible to do with conventional approaches. When the first reverse vaccinology project was started, in the year 2000, antigen identification was mainly based on bioinformatic analysis of one genome. Since then, the technique has shown its full potential, with the first genome-derived vaccine now in clinical trials and several vaccines in preclinical studies. In the meantime the approach has been improved with the support of proteomics, functional genomics and comparative genomics. The complete process includes antigen prediction to high-throughput purification, screening and selection of the vaccine composition.
Further reading: Vaccine Design: Innovative Approaches and Novel Strategies
Streptomyces book
Paul Dyson (Institute of Life Sciences, School of Medicine, Swansea, UK) presents a new book on Streptomyces: Molecular Biology and Biotechnology
Streptomycetes are Gram-positive, high GC-content, sporulating bacteria found predominantly in soil. Streptomycetes are characterised by a complex secondary metabolism producing antibiotic compounds and other metabolites with medicinal properties. In recent years genomic studies, genomic mining and biotechnological approaches have been employed in the search for new antibiotics and other drugs.
With contributions from some of the leading scientists in the field, this volume documents recent research and development in streptomycetes genomics, physiology and metabolism. With a focus on biotechnology and genomics, the book provides an excellent source of up-to-date information. Topics include: genome architecture, conjugative genetic elements, differentiation, protein secretion, central carbon metabolic pathways, regulation of nitrogen assimilation, phosphate control of metabolism, gamma-butyrolactones and their role in antibiotic regulation, clavulanic acid and clavams, genome-guided exploration, gene clusters for bioactive natural products, genomics of cytochromes p450.
Streptomycetes are Gram-positive, high GC-content, sporulating bacteria found predominantly in soil. Streptomycetes are characterised by a complex secondary metabolism producing antibiotic compounds and other metabolites with medicinal properties. In recent years genomic studies, genomic mining and biotechnological approaches have been employed in the search for new antibiotics and other drugs.
With contributions from some of the leading scientists in the field, this volume documents recent research and development in streptomycetes genomics, physiology and metabolism. With a focus on biotechnology and genomics, the book provides an excellent source of up-to-date information. Topics include: genome architecture, conjugative genetic elements, differentiation, protein secretion, central carbon metabolic pathways, regulation of nitrogen assimilation, phosphate control of metabolism, gamma-butyrolactones and their role in antibiotic regulation, clavulanic acid and clavams, genome-guided exploration, gene clusters for bioactive natural products, genomics of cytochromes p450.
 | Edited by: Paul Dyson ISBN: 978-1-904455-77-6 Publisher: Caister Academic Press Publication Date: January 2011 Cover: hardback |
Essential reading for research scientists, biotechnologists, graduate students and other professionals involved in streptomycetes research, antibiotic and antimicrobial development, drug discovery, soil microbiology and related fields. A recommended text for all microbiology laboratories.
Small DNA Binding Proteins in Bacteria
Integrity of the bacterial genome is essential to survival of the organism. Further, the size of the bacterial cell necessitates significant compaction of the genomic DNA, yet availability to various cellular machineries is important for cell growth. A variety of small DNA-binding proteins encompass these functions. These proteins are sometimes referred-to as histone-like, not because of sequence or structural similarity to eukaryotic histones, but because of comparable roles in nucleoid compaction. A number of such nucleoid-associated proteins have been identified in Escherichia coli, including H-NS, Fis, Dps (DNA protection during starvation), HU, and IHF (Integration Host Factor), all of which are present at concentrations up to or even exceeding 10 mM, depending on growth conditions. These proteins have different DNA-binding properties and function together (and sometimes opposing each other) to organize genomic DNA and to regulate DNA-dependent activities.
Further reading: Functional Evolution of Bacterial Histone-Like HU Proteins
Further reading: Functional Evolution of Bacterial Histone-Like HU Proteins